Africa's life sciences sector is booming and there is an ongoing biotech startup revolution. Biotechnology is an industry focused on manipulating living organisms to create commercial products. It's hard to describe the exciting and mind-blowing scientific discoveries and medical innovations coming out of the African continent right now. So I decided to do a podcast in which I get the actors to tell their stories. Each episode will be packed with powerful information to excite, educate, enlighten, and encourage you. These breakthroughs are already beginning to change the world for example, the next breakthroughs in genetic research are expected to come out of my beloved continent. Join my guests as they tell us how their innovation is addressing challenges in health, agriculture, and environment. Experts estimate that the Biotech sector will surge beyond $775 billion in size by 2024. Africa is not getting left behind! Grab a front row seat and fasten your seat belt for this exciting ride. Smart students, academics, bioentrepreneurs, and investors will buckle up and learn as much as they can about navigating the journey from idea to market. But don't delay: subscribe to the podcast now and share with a friend.
This session focuses on the essential legal and funding strategies for early-stage biotech startups, emphasizing the importance of intellectual property (IP) management, legal structures, and the role of due diligence in attracting investors. The panel discusses common pitfalls, the significance of contracts, and the challenges of commercializing university IP. They also explore the timing of freedom to operate studies and the evolving landscape of biotech investment.
For this session, the featured guests were:
Chyreene Truluck – Partner at Spoor & Fisher, specializing in intellectual property (IP) law and IP management strategies.
Dr Vuyisile Phehane – Executive Manager of UJInvnt Pty Ltd, the Intellectual Property (IP) commercialization company of the University of Johannesburg, South Africa
Lucie Arntz – Senior Associate at Hogan Lovells, one of the world's top law firms with 2,532 lawyers working from 51 destinations around the globe.
Takeaways
Intellectual property is crucial for competitive advantage in biotech.
Startups should consider outsourcing legal services to manage costs.
Choosing the right legal structure is vital for biotech startups.
Understanding IP management is essential for attracting funding.
Collaboration agreements must clearly define IP ownership and rights.
Due diligence is critical for investors assessing biotech startups.
Patents provide public protection, while trade secrets require confidentiality.
Commercialization often requires significant investment beyond R&D costs.
Startups should be open to acquisition opportunities.
Timing and strategic planning are key to successful biotech ventures.
29 Oct 2024
AMA Series on Investment Funding for Biotech - Legal Essentials for Biotech Startups
This session focuses on the essential legal and funding strategies for early-stage biotech startups, emphasizing the importance of intellectual property (IP) management, legal structures, and the role of due diligence in attracting investors. The panel discusses common pitfalls, the significance of contracts, and the challenges of commercializing university IP. They also explore the timing of freedom to operate studies and the evolving landscape of biotech investment.
For this session, the featured guests were:
Chyreene Truluck – Partner at Spoor & Fisher, specializing in intellectual property (IP) law and IP management strategies.
Dr Vuyisile Phehane – Executive Manager of UJInvnt Pty Ltd, the Intellectual Property (IP) commercialization company of the University of Johannesburg, South Africa
Lucie Arntz – Senior Associate at Hogan Lovells, one of the world's top law firms with 2,532 lawyers working from 51 destinations around the globe.
Takeaways
Intellectual property is crucial for competitive advantage in biotech.
Startups should consider outsourcing legal services to manage costs.
Choosing the right legal structure is vital for biotech startups.
Understanding IP management is essential for attracting funding.
Collaboration agreements must clearly define IP ownership and rights.
Due diligence is critical for investors assessing biotech startups.
Patents provide public protection, while trade secrets require confidentiality.
Commercialization often requires significant investment beyond R&D costs.
Startups should be open to acquisition opportunities.
Timing and strategic planning are key to successful biotech ventures.
16 Sept 2024
OneBio Innovation Center: A Pioneering Space for Biotech Startups in Africa
In this episode of the Africa Biotech Conversations Podcast, host Adrienne Leussa welcomes Erin Rencken, General Manager of the newly launched OneBio Innovation Center (OBIC) in Cape Town, South Africa.
The special episode features a live recording from the launch event and a detailed discussion about OBIC's mission, offerings, and community-building efforts.
Erin outlines the center's vision to provide biotech startups with essential lab space, equipment, and a collaborative environment. The conversation also highlights the support received from the Technology Innovation Agency (TIA), private sector partners like Eppendorf, and the center's focus on inclusivity and community engagement through initiatives like Biotech and Beers.
The episode emphasizes the center's role in fostering biotech innovation in Africa, offering a world-class facility for emerging entrepreneurs in the field.
00:58 MeetErin Rencken: General Manager of OBIC
03:05 Vision and Goals of OBIC
05:47 Resources and Facilities at OBIC
09:02 Community and Collaboration
11:14 Partnerships and Future Plans
19:06 Inclusivity and Accessibility
21:10 Joining OBIC: Process and Opportunities
25:20 Erin Rencken's Personal Journey and Vision
27:39 Reflecting on the Journey
28:00 Empowering Women in Biotech
29:10 Invitation to OneBio Innovation Center
29:52 Biotech and Beers Event Details
31:49 Introduction to OneBio Innovation Center
32:56 Overview of Lab Facilities
36:53 Community and Office Space
38:10 Acknowledgements and Thank Yous
43:59 Eppendorf's Contribution and Vision
49:14 Honoring Michael Fichardt
50:02 Closing Remarks and Celebration
Inside a recent episode
Legal Essentials for Biotech Startups
Published 29 Oct 2024 · Transcript excerpt
[…] But how then do you go about protecting your IP and making sure that if you are putting in the investment to protect your IP and file patents that you actually utilize that? and not just spend that money without it being part of your strategy and just what that strategy is as well, to be very clear about that. I know when we spoke offline, you mentioned something about the three pillars of IP management. Do you care to elaborate on that? Yeah, sure. So, I mean, those three pillars of IP management are first pillar, protecting, So that involves figuring out what it is you have, what it is that is even protectable, and then whether it's worthwhile doing that and where. […]
Pod Engine is an independent podcast discovery and analytics service and is not affiliated with or endorsed by this podcast. Artwork and show content belong to their owners. Full legal notice.
Explore this show Podcast research with Pod Engine
